# Dianthus Therapeutics, Inc.: Form 8-K, filed Jun 7, 2021

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2021-06-07
- Accepted by EDGAR: Jun 7, 2021, 08:09 ET
- Period: 2021-06-01
- Accession: 0001193125-21-183770
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312521183770/d160787d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312521183770/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312521183770/d160787d8k.htm

Filed Jun 7, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-183770. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.
